ROME III Functional Dyspepsia Criteria: Substantial Symptom Overlap With GERD Questions Their Validity

2011 ◽  
Vol 140 (5) ◽  
pp. S-188 ◽  
Author(s):  
Nimish B. Vakil ◽  
Katarina Halling ◽  
Börje Wernersson ◽  
Lis Ohlsson
Author(s):  
Desiree F. Baaleman ◽  
Carlos A. Velasco-Benítez ◽  
Laura M. Méndez-Guzmán ◽  
Marc A. Benninga ◽  
Miguel Saps

AbstractTo evaluate the agreement between the Rome III and Rome IV criteria in diagnosing pediatric functional gastrointestinal disorders (FGIDs), we conducted a prospective cohort study in a public school in Cali, Colombia. Children and adolescents between 11 and 18 years of age were given the Spanish version of the Questionnaire on Pediatric Functional Gastrointestinal Disorders Rome III version on day 0 and Rome IV version on day 2 (48 h later). The study protocol was completed by 135 children. Thirty-nine (28.9%) children were excluded because of not following the instructions of the questionnaire. The final analysis included data of 96 children (mean 15.2 years old, SD ± 1.7, 54% girls). Less children fulfilled the criteria for an FGID according to Rome IV compared to Rome III (40.6% vs 29.2%, p=0.063) resulting in a minimal agreement between the two criteria in diagnosing an FGID (kappa 0.34, agreement of 70%). The prevalence of functional constipation according to Rome IV was significantly lower compared to Rome III (13.5% vs 31.3%, p<0.001), whereas functional dyspepsia had a higher prevalence according to Rome IV than Rome III (11.5% vs 0%).Conclusion: We found an overall minimal agreement in diagnosing FGIDs according to Rome III and Rome IV criteria. This may be partly explained by the differences in diagnostic criteria. However, limitations with the use of questionnaires to measure prevalence have to be taken into account. What is Known:• The Rome IV criteria replaced the previous Rome III criteria providing updated criteria to diagnose functional gastrointestinal disorders (FGIDs).• Differences found between Rome IV and historic Rome III FGID prevalence may have been affected by changes in prevalence over time or differences in sample characteristics. What is New:• We found a minimal agreement between Rome III and Rome IV FGID diagnosis, especially in the diagnoses of functional constipation, irritable bowel syndrome, and functional dyspepsia.• The minimal agreement may be partly explained by changes in diagnostic criteria, but limitations with the use of questionnaires to measure prevalence have to be taken into account.


2015 ◽  
Vol 28 (2) ◽  
pp. 196-205 ◽  
Author(s):  
J. K. Dibaise ◽  
R. S. Islam ◽  
A. C. Dueck ◽  
M. C. Roarke ◽  
M. D. Crowell

2017 ◽  
Vol 112 (1) ◽  
pp. 132-140 ◽  
Author(s):  
H Vanheel ◽  
F Carbone ◽  
L Valvekens ◽  
M Simren ◽  
H Tornblom ◽  
...  

2019 ◽  
Vol 9 (2) ◽  
pp. 321-324 ◽  
Author(s):  
Vahideh Ebrahimzadeh Attari ◽  
Mohammad Hosein Somi ◽  
Mohammad Asghari Jafarabadi ◽  
Alireza Ostadrahimi ◽  
Seyed-Yaghob Moaddab ◽  
...  

Purpose: The present study aimed to assess the effect of ginger (Zingiber officinale) powder supplementation on Helicobacter pylori eradication and improvement of dyspeptic symptoms in patients with H. pylori positive functional dyspepsia (FD). Methods: During this pilot study 15 patients with H. pylori positive FD received 3 g/d ginger powder as three 1-g tablets for 4-weeks. Dyspepsia symptoms were asked before and after the intervention using a questionnaire based on the Rome III criteria. H. pylori eradication was also assessed by a non-invasive stool antigen (HpSAg) test. Results: Ginger consumption accompanied by significant H. pylori eradication rate of 53.3% (P = 0.019) and the odds ratio (95% CI) was 8 (1.07 to 357.14). Moreover, our results showed significant changes in most of the dyspepsia symptoms after ginger supplementation. Conclusion: According to our findings, Z. officinale can be considered as a useful complementary therapy for FD. However, due to the small number of clinical trials in this area, further welldesigned clinical trials are needed to explicitly talk about its effectiveness especially about the eradication of H. pylori.


2010 ◽  
Vol 105 (12) ◽  
pp. 2626-2631 ◽  
Author(s):  
Ying-Lian Xiao ◽  
Sui Peng ◽  
Jin Tao ◽  
An-Jiang Wang ◽  
Jin-Kun Lin ◽  
...  

2009 ◽  
Vol 136 (5) ◽  
pp. A-184
Author(s):  
Masahiro Ochi ◽  
Kazunari Tominaga ◽  
Hirotoshi Okazaki ◽  
Tetsuya Tanigawa ◽  
Hirokazu Yamagami ◽  
...  

2008 ◽  
Vol 8 (1) ◽  
Author(s):  
AnJiang WANG ◽  
XianHua LIAO ◽  
LiShou XIONG ◽  
Sui PENG ◽  
YingLian XIAO ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document